Systemic and mucosal pre-administration of recombinant<i>Helicobacter pylori</i>neutrophil-activating protein prevents ovalbumin-induced allergic asthma in mice

Abstract

Systemic and mucosal pre-administration of rNAP could suppress the development of OVA-induced asthma in mice; rNAP may be utilized as part of novel strategies for the prevention or treatment of allergic diseases.